| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |